SynOx Therapeutics Raises $75M in Series B Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Jon Edwards. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
SynOx Therapeutics has raised $75m in Series B financing, co-led by Forbion, HealthCap and new investor Bioqube Ventures.
Biopharmaceutical company SynOx Therapeutics has raised $75m (€70.5m) to continue its development of a treatment for Tenosynovial Giant Cell Tumour (TGCT).
A loan extension, purchase of IP and £900k fundraise are fuelling hopes
LANGLEY, BC / ACCESSWIRE / April 2, 2024 / Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian concentrates brands, with